The Tether™ Innovative Treatment for Young Patients with Scoliosis Receives FDA Approval

WARSAW, Ind., Aug. 16, 2019 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration approval for The Tether™ for treatment of scoliosis, providing a fusion-less alternative for young patients requiring surgery.

Press Releases FDA
Clinical Trials
Related News